Each year, UMDF’s Mitochondrial Medicine Symposium brings together the best minds in mitochondrial medicine and the patients. In 2021, UMDF will virtually reach out to thousands across the U.S. and around the world. The Symposium is recognized as the world’s preeminent event for mitochondrial disease.
GenSight Biologics is a Bronze sponsor of the 2021 edition.
Dr Magali Taiel, Chief Medical Officer, will participate in a moderated panel discussion on clinical trial updates.
Friday, June 25 – 12:00pm-5:00pm EDT
- 1:15pm – Clinical Trials Panel #1 Discussion – Gensight Biologics, Minovia Therapeutics, PTC Therapeutics, and University of Florida